Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05815485
Status:
RECRUITING
Last Update Posted:
2023-10-31
First Post:
2023-04-13
Brief Title:
A Randomized Double-Blind Placebo-Controlled Phase 23 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 COVID-19 or Pneumonia
Sponsor:
Salim S Hayek
Organization:
University of Michigan
Organization Data
Organization:
University of Michigan
Class:
OTHER
Study ID:
HUM00221960
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Salim S Hayek
Lead Sponsor Class:
OTHER
Responsible Party:
Salim S Hayek
Responsible Party Title:
Assistant Professor of Internal Medicine and Medical Director UMMG
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Michigan
Old Name:
None
Old Organization:
None